Radioimmunotherapy with engineered antibodies (Q35681517)

9 August 2017

1 reference

title

Radioimmunotherapy with engineered antibodies (English)

1 reference

9 August 2017

Maria G Russeva

1

1 reference

9 August 2017

Gregory P Adams

series ordinal

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Expert Opinion on Biological Therapy

9 August 2017

1 reference

9 August 2017

4

1 reference

9 August 2017

2

1 reference

9 August 2017

217-231

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

9 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Multiple roles for the major histocompatibility complex class I- related receptor FcRn

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Replacing the complementarity-determining regions in a human antibody with those from a mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Comparison of IgG diffusion and extracellular matrix composition in rhabdomyosarcomas grown in mice versus in vitro as spheroids reveals the role of host stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Preparation and biological evaluation of polymerizable antibody Fab' fragment targeted polymeric drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Computational approach for determining the spectrum of DNA damage induced by ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Tumor therapy with targeted atomic nanogenerators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Comparative Physical and Pharmacologic Characteristics of Iodine-131 and Yttrium-90: Implications for Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Experimental radioimmunotherapy with 186Re-MAG3-A7 anti-colorectal cancer monoclonal antibody: comparison with 131I-counterpart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Pretargeting with the affinity enhancement system for radioimmunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Antibody-targeted immunotherapy for treatment of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Phase I radioimmunotherapy trial with iodine-131--labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Radioimmunotherapy of small-volume disease of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Construction, expression and tumor targeting of a single-chain Fv against human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Radionuclides and carrier molecules for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

Production of functional chimaeric mouse/human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.2.217

21 January 2018

Identifiers

DOI

10.1517/14712598.4.2.217

1 reference

release_nvt7njqe7bfb3p76tcz2y62bxe

9 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nvt7njqe7bfb3p76tcz2y62bxe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference